TAT 13 International Symposium and 19th Edwaldo Camargo Symposium

Scientific Committees


13th International Symposium of Targeted Alpha Therapy (TAT 13)

Chairperson: Mike Sathekge - University of Pretoria, South Africa

Africa

Mariza Vorster

University of KwaZulu-Natal, SOUTH AFRICA

Asia/Oceania

Kohshin Washiyama

Fukushima Medical University, JAPAN

Ilhan Lim

Korea Institute of Radiological & Medical Sciences, SOUTH KOREA

Michael Hofman

Melbourne's Peter MacCallum Cancer Centre, AUSTRALIA

Europe

Frank Bruchertseifer

European Commission, Joint Research Centre, Karlsruhe, GERMANY

Janke Kleynhans

KU Leuven, BELGIUM

Clemens Kratochwil

University Hospital Heidelberg, GERMANY

Jan Kozempel

Prague Technical University, CZECH REPUBLIC

Jolanta Kunikowska

Medical University Warsaw, POLAND

Jean-Pierre Pouget

INSERM Montpellier, FRANCE

Latin America

Camila Mosci

SBMN & Rede D´Or, BRAZIL

Letícia Rigo

AC Camargo, BRAZIL

Vasko Kramer

Positron Pharma, CHILE

Eduardo Savio

CUDIM, URUGUAY

United States of America / Canada

Jason Lewis

Memorial Sloan Kettering Cancer Centre, UNITED STATES OF AMERICA

Valery Radchenko

TRIUMF Vancouver, CANADA

Lionel Zuckier

Columbia University, UNITED STATES OF AMERICA

Michael Zalutsky

Duke University, UNITED STATES OF AMERICA

19th Edwaldo Camargo Symposium

Chairperson: Allan Santos – SBMN &  MND group & UNICAMP, BRAZIL  

Flávia Paiva

SBMN & INCA, RIO DE JANEIRO

Claudio Tinoco

UFRJ, RIO DE JANEIRO 

Sérgio Almeida

Rede D´Or, RIO DE JANEIRO

Felipe Villela Pedras

Clínica de Medicina Nuclear Villela Pedras, RIO DE JANEIRO

Paulo Rosado Castro

Perceptive Inc., RIO DE JANEIRO